| Severe COVID-19 is marked by a dysregulated myeloid cell compartment J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... Cell 182 (6), 1419-1440. e23, 2020 | 1418 | 2020 |
| Human monocyte subsets and phenotypes in major chronic inflammatory diseases TS Kapellos, L Bonaguro, I Gemünd, N Reusch, A Saglam, ER Hinkley, ... Frontiers in immunology 10, 2035, 2019 | 889 | 2019 |
| Neutrophils in COVID-19 N Reusch, E De Domenico, L Bonaguro, J Schulte-Schrepping, K Baßler, ... Frontiers in immunology 12, 652470, 2021 | 320 | 2021 |
| Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients AC Aschenbrenner, M Mouktaroudi, B Krämer, M Oestreich, N Antonakos, ... Genome medicine 13, 1-25, 2021 | 258 | 2021 |
| Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 B Krämer, R Knoll, L Bonaguro, M ToVinh, J Raabe, ... Immunity 54 (11), 2650-2669. e14, 2021 | 211 | 2021 |
| Cannabinoid receptor 2 is necessary to induce toll‐like receptor‐mediated microglial activation N Reusch, KA Ravichandran, BF Olabiyi, JA Komorowska‐Müller, ... Glia 70 (1), 71-88, 2022 | 31 | 2022 |
| Suppressive myeloid cells are a hallmark of severe COVID-19 J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... MedRxiv, 2020.06. 03.20119818, 2020 | 30 | 2020 |
| Alveolar macrophages in early stage COPD show functional deviations with properties of impaired immune activation K Baßler, W Fujii, TS Kapellos, E Dudkin, N Reusch, A Horne, B Reiz, ... Frontiers in immunology 13, 917232, 2022 | 27 | 2022 |
| Alterations of multiple alveolar macrophage states in chronic obstructive pulmonary disease K Baßler, W Fujii, TS Kapellos, A Horne, B Reiz, E Dudkin, M Lücken, ... BioRxiv, 2020.05. 28.121541, 2020 | 16 | 2020 |
| Mature neutrophils and a NF-κB-to-IFN transition determine the unifying disease recovery dynamics in COVID-19 A Frishberg, E Kooistra, M Nuesch-Germano, T Pecht, N Milman, ... Cell Reports Medicine 3 (6), 2022 | 12 | 2022 |
| Induction of Rosette-to-Lumen stage embryoids using reprogramming paradigms in ESCs J Langkabel, A Horne, L Bonaguro, L Holsten, T Hesse, A Knaus, ... Nature Communications 12 (1), 7322, 2021 | 10 | 2021 |
| Identification of drug candidates targeting monocyte reprogramming in people living with HIV R Knoll, L Bonaguro, JC Dos Santos, S Warnat-Herresthal, ... Frontiers in immunology 14, 1275136, 2023 | 7 | 2023 |
| Diseas e severity-specific neutrophil signatures in blood transcriptomes stratify COVID-1 9 patients, medRxiv (2020) AC Aschenbrenner, M Mouktaroudi, B Kraemer, N Antonakos, ... PMID, 0 | 2 | |
| Revisiting the innate immune response-a temporal resolution of whole blood stimulation N Reusch, S Mueller, K Bassler, L Bonaguro, J Schulte-Schrepping, ... EUROPEAN JOURNAL OF IMMUNOLOGY 52, 12-13, 2022 | | 2022 |
| The Femmunity study: elucidating the dynamic of the female peripheral immune system during menstrual cycle T Pecht, J Loesch, L Holsten, N Reusch, AM Schieren, S Koch, ... EUROPEAN JOURNAL OF IMMUNOLOGY 52, 385-386, 2022 | | 2022 |
| ERA-CVD Verbund" AtheroMacHete"-Makrophagen-Heterogenität bei Arteriosklerose im Mausmodell und beim Menschen: Eine therapeutische Gelegenheit?: Schlussbericht: Laufzeit des … JL Schultze, T Ulas, M van Uelft, N Reusch Universität Bonn, 2022 | | 2022 |
| Induction of peri-implantation stage synthetic embryos using reprogramming paradigms in ESCs J Langkabel, A Horne, L Bonaguro, T Hesse, A Knaus, Y Riedel, ... bioRxiv, 2021.01. 25.428068, 2021 | | 2021 |